Biovest AgentPotential Partnering
Potential partnering database.
Biotech Events
Biotech event calendar and key milestones.
Mindmap
Highlight the main evaluation criteria of potential biotech partnering opportunities (preclinical/early clinical)
Deck/Asset Analysis
Analyze a company or asset deck for fit to Alfasigma, covering snapshot, unmet need, modality, criteria scores, and recommendation.
Competitive Landscape
Competitive landscape of a particular modality, field or indication.
Technical Analysis
Technical analysis of a new technology or landscape in a particular indication.
Key Opinion Leaders
Identify leading KOLs with scoring, snapshots, visuals, and engagement recommendations.
Investment Trends
Executive summary of funding and partnering trends for a modality/indication with implications and recent deals.
Deep Due Diligence
Full investor memo covering USP, science, plan, regulatory, CMC, IP, market, team, finances, and key questions.
Bankers Report
Sell-side memo with market, epidemiology, pricing, rNPV model, comps, sensitivities, and appendix.
Freedom to Operate
FTO analysis with patent tables, blocking claims, licensing, litigation, risk matrix, and mitigations.
CEO Profiling
CEO dossier on scientific record, leadership, exits, investors, company performance, and risks.
Headhunter Brief
Shortlist and benchmark of 20+ CEO candidates with bios, scoring, and outreach plan.
Leading Scientists
Scout 20+ researchers for a scientific challenge with profiles, scorecard, and partnership guidance.
Investment Target Landscape
Excel landscape of pre-approval companies with selection criteria, universe table, shortlist, scoring matrix, and recommendations.
Preliminary Asset Evaluation
Clinical-stage asset evaluations (Phase I—III or marketed)